It has been suggested that activation of SIRT3 causes a switch from glycolysis to oxidative phosphorylation and activation of the tricarboxylic acid (TCA) cycle, subsequently slowing down tumour cell growth [35]. Here, SIRT3 is linked to neoplasm.